AVITA Medical Income Statement (2018-2025) | RCEL

Income Statement Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025
Revenue & cost
Revenue 0.27M1.04M1.71M2.46M3.25M3.26M3.88M3.88M5.06M5.10M8.77M10.30M7.02M7.54M8.34M9.09M9.46M10.55M11.75M13.64M14.20M11.10M15.20M19.55M9.43M18.51M18.42M17.06M92.00M
Cost of Revenue 2.16M2.84M3.31M3.94M3.10M3.97M4.38M4.26M3.27M3.60M3.65M4.15M3.52M4.83M5.33M5.41M6.34M6.54M10.00M10.53M10.22M12.64M16.30M15.14M-34.99M14.83M14.31M12.05M-28.41M
Gross Profit 0.04M0.80M1.42M1.95M2.63M2.41M3.24M3.00M4.13M4.28M6.62M8.25M5.93M5.76M6.95M7.56M8.11M8.88M9.55M11.53M12.40M9.59M13.08M16.36M16.13M15.68M14.95M13.88M14.31M
Operating items
Research & Development 1.97M2.02M1.81M2.07M1.82M2.31M2.50M2.54M3.37M3.36M4.11M3.97M3.39M3.62M3.06M3.80M3.38M4.59M5.08M4.39M6.76M5.19M4.89M5.43M-35.87M6.28M5.12M3.75M-35.99M
Selling, General & Administrative 2.60M3.40M3.65M3.93M3.42M7.11M12.79M9.71M8.30M3.40M5.42M5.28M5.35M7.53M5.47M5.00M5.32M8.29M6.17M6.12M7.75M8.96M7.52M9.59M-59.27M6.39M6.67M7.23M-47.66M
Other Operating Expenses 2.38M3.43M3.88M4.51M2.05M0.39M1.01M0.48M0.60M0.45M0.57M0.44M0.37M0.73M0.55M0.90M1.03M0.63M0.53M0.21M0.06M12.64M16.30M15.14M-102.28M14.83M14.31M12.05M-94.34M
Operating Expenses 6.96M8.85M9.34M10.51M8.34M13.39M19.66M16.51M14.94M10.36M13.18M13.39M12.26M15.98M13.86M14.21M15.04M19.42M21.24M21.05M24.73M26.80M28.71M30.16M-197.42M27.51M26.10M23.03M-177.98M
Operating Income -5.06M-6.30M-6.68M-7.49M-3.66M-10.59M-15.41M-13.02M-10.21M-5.63M-5.99M-4.70M-5.95M-9.49M-6.36M-5.75M-5.91M-9.91M-11.16M-9.31M-12.27M-17.21M-15.62M-13.81M-9.96M-11.83M-11.15M-9.15M-10.41M
EBIT -5.06M-6.30M-6.68M-7.49M-3.66M-10.59M-15.41M-13.02M-10.21M-5.63M-5.99M-4.70M-5.95M-9.49M-6.36M-5.75M-5.91M-9.91M-11.16M-9.31M-12.27M-17.21M-15.62M-13.81M-9.96M-11.83M-11.15M-9.15M-10.41M
Non-operating items
Interest & Investment Income 0.05M
Other Non Operating Income 0.10M0.10M0.36M0.12M0.00M0.00M0.01M0.00M0.02M0.03M0.11M0.17M0.58M0.72M0.80M0.61M6.34M-0.07M1.61M-1.07M-0.21M-0.79M2.48M-2.75M0.02M
Non Operating Income 0.10M0.10M0.36M0.12M0.00M0.00M0.01M0.00M0.72M0.80M0.61M6.34M-0.07M1.61M-1.07M-0.32M-0.79M2.48M-2.75M0.02M
Net income details
EBT -5.03M-6.27M-6.18M-7.75M-3.57M-10.50M-15.05M-12.91M-10.22M-5.63M-5.99M-4.71M-5.94M-9.46M-6.26M-5.58M-5.46M-9.19M-10.37M-8.70M-16.43M-18.63M-15.36M-16.23M-11.57M-13.85M-9.92M-13.17M-11.64M
Tax Provisions 0.01M-0.13M0.00M0.01M0.01M0.01M0.01M0.01M0.00M0.00M0.00M0.02M0.03M0.01M0.01M0.01M0.03M0.03M-0.03M-0.09M0.01M0.00M0.01M-0.04M
Profit After Tax -5.03M-6.27M-6.18M-7.62M-3.57M-10.50M-15.05M-12.91M-10.23M-5.64M-6.00M-4.72M-5.95M-9.46M-6.26M-5.59M-5.35M-9.22M-10.38M-8.71M-7.07M-18.66M-15.39M-16.20M-11.48M-13.86M-9.92M-13.19M-11.60M
Income from Continuing Operations -5.03M-6.27M-6.18M-7.62M-3.57M-10.50M-15.05M-12.91M-10.23M-5.64M-6.00M-4.72M-5.95M-9.46M-6.26M-5.59M-5.49M-9.22M-10.38M-8.71M-16.44M-18.66M-15.39M-16.20M-11.48M-13.86M-9.92M-13.19M-11.60M
Consolidated Net Income -5.03M-6.27M-6.18M-7.62M-3.57M-10.50M-15.05M-12.91M-10.23M-5.64M-6.00M-4.72M-5.95M-9.46M-6.26M-5.59M-5.49M-9.22M-10.38M-8.71M-16.44M-18.66M-15.39M-16.20M-11.48M-13.86M-9.92M-13.19M-11.60M
Income towards Parent Company -5.03M-6.27M-6.18M-7.62M-3.57M-10.50M-15.05M-12.91M-10.23M-5.64M-6.00M-4.72M-5.95M-9.46M-6.26M-5.59M-5.49M-9.22M-10.38M-8.71M-16.44M-18.66M-15.39M-16.20M-11.48M-13.86M-9.92M-13.19M-11.60M
Net Income towards Common Stockholders -5.03M-6.27M-6.18M-7.62M-3.57M-10.50M-15.05M-12.91M-10.23M-5.64M-6.00M-4.72M-5.95M-9.46M-6.26M-5.59M-5.49M-9.22M-10.38M-8.71M-16.44M-18.66M-15.39M-16.20M-11.48M-13.86M-9.92M-13.19M-11.60M
Additional items
EPS (Basic) -0.38-0.44-0.34-0.41-0.19-0.53-0.71-0.600.48-0.260.26-0.210.240.380.250.220.22-0.37-0.41-0.34-0.28-0.73-0.60-0.62-0.53-0.38-0.46
EPS (Weighted Average and Diluted) -0.38-0.44-0.34-0.41-0.19-0.53-0.71-0.600.48-0.260.26-0.210.240.380.250.220.22-0.37-0.41-0.34-0.28-0.73-0.60-0.62-0.53-0.38-0.46
Shares Outstanding (Weighted Average) 13.24M18.26M21.22M21.37M21.50M21.62M22.73M22.67M24.91M24.92M24.94M24.97M25.01M25.00M25.20M25.24M25.40M25.33M25.64M25.76M25.98M26.25M26.40M28.39M
Shares Outstanding (Diluted Average) 13.24M18.26M21.22M21.37M21.50M21.62M22.73M22.67M24.91M24.92M24.94M24.97M25.01M25.00M25.20M25.24M25.40M25.33M25.64M25.76M25.98M26.25M26.40M28.39M
EBITDA -5.06M-6.30M-6.68M-7.49M-3.66M-10.59M-15.41M-13.02M-10.21M-5.63M-5.99M-4.70M-5.95M-9.49M-6.36M-5.75M-5.91M-9.91M-11.16M-9.31M-12.27M-17.21M-15.62M-13.81M-9.96M-11.83M-11.15M-9.15M-10.41M
Interest Expenses 0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.00M0.00M0.01M0.01M0.00M0.01M0.01M0.00M0.01M0.01M1.12M1.36M1.35M1.36M-9.42M1.23M1.25M1.27M-8.76M
Tax Rate -0.14%1.65%-0.03%-0.10%-0.20%-0.17%-0.15%-0.10%-0.04%-0.06%-0.07%-0.44%-0.33%-0.13%-0.13%-0.07%-0.16%-0.21%0.17%0.77%-0.06%-0.04%-0.11%0.34%